Anterior Versus Transforaminal Lumbar Interbody Fusion: Perioperative Risk Factors and 30-Day Outcomes ====================================================================================================== * PAVAN S. UPADHYAYULA * ERIK I. CURTIS * JOHN K. YUE * NIKKI SIDHU * JOSEPH D. CIACCI ## ABSTRACT **Background:** Operative management of lower back pain often necessitates anterior lumbar interbody fusion (ALIF) or transforaminal lumbar interbody fusion (TLIF). Specific pathoanatomic advantages and indications exist for both approaches, and few studies to date have characterized comparative early outcomes. **Methods:** Adult patients undergoing elective ALIF or TLIF operations were abstracted from the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) years 2011–2014. Univariate analyses were performed by surgery cohort for each outcome and adjusted for demographic/clinical variables (age ≥ 65, sex, race, body mass index, American Society of Anesthesiologists physical classification score, functional status, inpatient/outpatient status, smoking, hypertension, Charlson Comorbidity Index) using multivariable regression. Means, standard errors, mean differences (*B*), odds ratios (ORs), and associated 95% confidence intervals (CIs) are reported. Significance was assessed at *P* < .05. **Results:** Of 8263 subjects (ALIF: 4325, TLIF: 3938), ALIF subjects were younger, less obese, less physically impaired, and had significantly lower rates of hypertension, diabetes, coagulopathy, and previous cardiac surgery. On multivariable analysis, ALIF associated with shorter operative time (*B* = −11.80 minutes, 95% CI [−16.48, −7.12]; *P* < .001). Transforaminal lumbar interbody fusion was associated with increased incidence of urinary tract infections (UTIs; OR = 1.57, 95% CI [1.10, 2.26]; *P* = .013) and of blood transfusions (OR = 1.19, 95% CI [1.04, 1.37]; *P* = .012). Multivariate analysis also demonstrated TLIF associated with shorter hospital length of stay (*B* = −0.27 days, 95% CI [−0.54, −0.01]; *P* = .041), and fewer cases of pneumonia (OR = 0.55, 95% CI [0.32, 0.94]; *P* = .029) and prolonged ventilator dependency (OR = 0.33, 95% CI [0.12, 0.84]; *P* = .021). **Conclusions:** Comparatively, ALIF patients experienced decreased operative time and decreased incidence of postoperative UTIs and blood transfusions. Anterior lumbar interbody fusion patients were more likely to suffer postoperative pulmonary complications and longer hospital stays. Our data support the notion that both anterior and transforaminal surgical approaches perform comparably in context of 30-day perioperative outcomes. * anterior lumbar interbody fusion * ACS-NSQIP * posterior lumbar interbody fusion * lumbar spine surgery * early complications * surgical outcomes * transforaminal lumbar interbody fusion * degenerative disc disease * low back pain * operation time ## INTRODUCTION In the Western world, the annual prevalence of lower back pain is estimated to be as high as 65% and lifetime prevalence as high as 84%.1 Sufferers often experience both a decrease in quality of life and a reduced workforce availability, with profound economic consequences. In the United States (US) alone, the annual direct (health care) and indirect (loss of work productivity) costs of back pain amount to over $100 billion.2 Lumbar spinal fusion is a viable option for patients with degenerative disc disease who fail aggressive nonsurgical management. Traditionally, surgical intervention with lumbar fusion is associated with improved acute and long-term outcomes compared with nonoperative treatment.3 Two primary surgical approaches to lumbar fusion in degenerative disease are anterior lumbar interbody fusion (ALIF) and transforaminal lumbar interbody fusion (TLIF). Anterior and posterior lumbar fusions were first described in the 1950s for the treatment of degenerative lumbar disease.4,5 Transforaminal lumbar interbody fusion, a modification to the posterior fusion technique using circumferential fusion through a single posterolateral approach, was subsequently described in 1982.6 A meta-analysis of 7 comparative studies demonstrated that TLIF has potential advantages over traditional posterior fusion, specifically in reducing postsurgical complications.7 Several studies highlight small relative advantages for TLIF over ALIF, including decreased operative time and lower complication rates.8,9 However, comparative advantages between the anterior and posterior approaches lack a clear consensus.10–12 This paper analyzes the differences in 30-day perioperative outcomes in patients who have undergone anterior versus posterior or transforaminal fusion. In using data from the prospectively collected American College of Surgeons (ACS) National Surgical Quality Improvement Project (NSQIP),13 we aim to provide insight into the comparative advantages and disadvantages between ALIF and TLIF surgical cohorts using population-wide data. In the present analysis, we assess the clinical presentation of patients and characterize key perioperative risk factors for each surgical cohort across outcome measures of operative time, mortality, early complications, hospital length of stay (HLOS), discharge destination, and unplanned reoperations. ## MATERIALS AND METHODS ### Data Source This retrospective analysis uses the ACS-NSQIP database created with the purpose of improving surgical outcomes and techniques.14 The NSQIP database focuses on demographic and clinical characteristics along with 30-day postoperative variables.15,16 From medical and/or operative records, over 300 perioperative variables are cataloged and included, spanning a time period up to 30 days postoperation.17 This analysis is exempt from institutional review board approval, as the ACS-NSQIP participant-use data files are in the public domain and contain no protected health information. ### Study Population This study analyzes the NSQIP database from the years 2011–2014 for all patients undergoing elective ALIF or TLIF. The ALIF and TLIF patients were identified using common procedural terminology (CPT) codes for single interspace procedures: 22558 (“Anterior Interbody Fusion, Lumbar”) references the ALIF CPT code for a single interspace, and 22630 (“Posterior Interbody Fusion, Lumbar” [PLIF]) references CPT code for PLIF or TLIF for single interspaces. This grouping of posterior fusion techniques—PLIF and TLIF—has previously been used in literature to isolate differences between anterior and posterior fusion approaches.18–21 It is also understood that PLIF procedures are coded by the same CPT codes used for TLIF procedures as both use a posterior approach with posterior instrumentation. Initially, 4490 ALIF and 4194 TLIF subjects were identified. Patients who underwent either emergent or nonelective surgeries (ALIF: 165, TLIF: 256) were removed to yield a final sample size of 8263 (ALIF: 4325, TLIF: 3938). Multilevel procedures were coded with additional CPT codes for each interspace: 22585 (“Anterior Interbody Fusion, Lumbar—Additional Interspace”) and 22632 (“Posterior Interbody Fusion, Lumbar—Additional Interspace”). ### Outcome Measures Six outcome measures were included in the current analysis: operation time, mortality, early complications, total HLOS, hospital discharge destination, and reoperation rate. Operation time is defined as the total length of surgery in minutes. Hospital length of stay is defined as the number of days between admission and postsurgery discharge. Both reoperation and complication were classified as a binary variables. If the patient had a reoperation, he or she was given a “yes”; otherwise, he or she was classified as a “no.” For complications, a “yes” value was given if a patient experienced a complication as recorded by 1 or more of the following variables: cardiac arrest, myocardial infarction, coma >24 hours, cerebrovascular accident/stroke with neurological deficit, peripheral nerve injury, wound/surgical site infection, urinary tract infection (UTI), renal insufficiency or failure, blood transfusion >1 unit, unplanned intubation, incidence of deep vein thrombosis/thrombophlebitis, sepsis or septic shock, pneumonia, pulmonary embolism, and death. The merits and drawbacks of such an approach will be discussed in the limitation section. Both HLOS and operation time were treated as continuous variables for univariate and multivariable analyses, and accordingly, linear regression was used. Hospital discharge destination was reclassified to either home or a facility of higher care (eg, rehabilitation center, skilled nursing facility, or acute care). Multivariable logistic regression was performed for reoperation, early complications, and discharge destination due to the categorical nature of the variables. Due to the confounding effects death may have on measures of HLOS and discharge destination, these analyses were performed on all patients not reported to have died within 30 days of operation (n = 8245). ## STATISTICAL METHODS All statistical analyses were performed using Python, an open source programming language. We thank the makers of the SciPy and StatsModels (source of materials ), as all statistics were computed using these packages.22–24 Continuous and categorical variables were compared between surgical cohorts using analysis of variance or χ2 tests, respectively. Multivariable linear regression was performed for linear outcome variables (operation time, HLOS). Multivariable logistic regression was performed on categorical outcome variables (discharge destination, complications, reoperation). All multivariable models were adjusted for the following demographic characteristics: age, gender, race, comorbidities, body mass index (BMI), functional status, inpatient/outpatient status, American Society of Anesthesiologists (ASA) score, and levels of vertebral fusion. Conforming to standard cutoffs published by the US Census Bureau, age was treated as a binary variable with elderly classified as ≥65 years.25 Body mass index (in kg/m2) was stratified according to World Health Organization classifications: underweight (<18.5), nonobese (18.5–29.9), obese class I (30–34.9), obese class II/III (≥35). Medical comorbidities were categorized using the Charlson Comorbidity Index (CCI),26 which has been widely used in retrospective spine studies as an summative indicator of baseline health burden.27–29 Hypertension and smoking, both associated with negative outcomes in a number of previous lumbar spine studies,30,31 were also analyzed independently. American Society of Anesthesiologists score was included as a validated indicator of physical morbidity in lumbar spine literature.32,33 Number of vertebral levels spanned was ascertained using CPT codes. Each patient thus had a number between 1 (single interspace) and 5 (five interspaces) indicating the number of spaces across which their fusion occurred. For linear regressions, mean difference (*B*) and 95% confidence intervals (CIs) are reported compared to reference values. For logistic regressions, odds ratios (ORs) and 95% CIs are reported. Significance was assessed at *P* < .05. Detailed information can be found in the tables section. ## RESULTS ### Demographic and Clinical Characteristics A total of 8263 patient records for elective ALIF or TLIF were abstracted from the ACS-NSQIP database years 2011–2014. Overall, subjects were 56.3 ± 13.7 years of age, and 54.5% were female. Subjects undergoing TLIF were more likely to be elderly (≥65 years: 35.6% versus 27.4%; *P* < .001). A higher percentage of subjects undergoing TLIF were obese (BMI <30 kg/m2: ALIF 49.9%, TLIF 47.2%; BMI >30 kg/m2: ALIF 48.1%, TLIF 51.2%; *P* = .001). Transforaminal lumbar interbody fusion subjects were more likely to be physically impaired (ASA 3–4: ALIF 38.5%, TLIF 43.6%; *P* < .001). Also, a greater proportion of ALIF patients had multilevel surgery (29.3% versus 25.5%; *P* = .003; Table 1). Transforaminal lumbar interbody fusion patients demonstrated greater likelihood of medical comorbidities as reported in Table 2. View this table: [Table 1](https://www.ijssurgery.com/content/12/5/533/T1) Table 1 Demographic and clinical characteristics by surgery cohort. Distributions and proportions are shown for elective lumbar spine surgery patients. View this table: [Table 2](https://www.ijssurgery.com/content/12/5/533/T2) Table 2 Comorbidities by surgery cohort. Distributions and proportions are shown for elective lumbar spine surgery patients. In total, 5994 (72.5%) underwent single-level interbody fusion by either anterior or posterior approaches. This included 3059 (70.7%) of the ALIF cohort and 2935 (74.5%) of the TLIF cohort. Only 391 (4.7%) total subjects had surgeries with >2 levels fused. Notably, in the ALIF group, 14.5% of subjects had nonsegmental posterior instrumentation used. ### Operation Time and Hospital Length of Stay (HLOS) The average operation time was 204.12 ± 110.51 minutes. On univariate analysis, ALIF showed significantly shorter operation times compared to TLIF cohort (ALIF: 198.36 ± 1.80 minutes, TLIF: 210.45 ± 1.60 minutes; *P* < .001; Table 3). This finding survived multivariable analysis with TLIF, showing a mean increase (*B*) of 11.80 minutes (95% CI [7.12, 16.48]; *P* < .001; Table 4). Male patients (*B* = 7.94 minutes; 95% CI [3.25, 12.62]; *P* = .001), obese patients (BMI >30: *B* = 6.72 minutes; 95% CI [1.09, 12.34]; *P* = .019), and ASA 3–4 (*B* = 19.36 minutes, 95% CI [13.98, 24.72]; *P* < .001) had longer operation times. In contrast, outpatients (*B* = −21.36 minutes, 95% CI [−36.12, −6.59]; *P* = .005) and smokers (*B* = −10.25 minutes, 95% CI [−15.90, −4.59]; *P* < .001) had shorter operation times (Table 4). View this table: [Table 3](https://www.ijssurgery.com/content/12/5/533/T3) Table 3 Univariate distribution of outcomes by surgery cohort. Distributions and proportions are shown for elective lumbar spine surgery patients. Mean hospital length of stay and hospital discharge to home analyses have a lower N due to excluding patients who expired in hospital and/or within 30 days of operation (ALIF: n = 4316; TLIF/PLIF: n = 3929). View this table: [Table 4](https://www.ijssurgery.com/content/12/5/533/T4) Table 4 Multivariable linear regression for operation time. Mean increase or decrease (*B*) and associated 95% confidence intervals (CIs) are shown for each predictor. Overall mean HLOS was 3.75 ± 0.06 days. Both univariate and multivariate analyses demonstrated a nonsignificant statistical trend to longer HLOS for ALIF subjects (Table 3). Both male (*B* = −0.62 days, 95% CI [−0.88, −0.35]; *P* < .001) and outpatient (*B* = −1.56 days, 95% CI [−2.39, −0.74]; *P* < .001) subjects had shorter hospital stays. Higher ASA score (ASA 3–4: *B* = 0.92 days, 95% CI [0.62, 1.22]; *P* < .001) and greater number of vertebral segments fused (*B =* 0.87, 95% CI [0.66, 1.09]; *P* < .001) were associated with increased HLOS (Table 5). View this table: [Table 5](https://www.ijssurgery.com/content/12/5/533/T5) Table 5 Multivariable linear regression for hospital length of stay (HLOS). Mean increase or decrease (*B*) and associated 95% confidence intervals (CI) are shown for each predictor. ### Failure of Hospital Discharge to Home and Mortality A total of 7127 patients or 86.4% of our dataset was discharged home. No significant difference was observed for surgery cohort and failure to be discharged home (ALIF: 12.9%, TLIF: 14.2%; *P* = .104; Table 3). Multivariable analysis further demonstrated this nonsignificant relationship (TLIF: OR 0.98, 95% CI [0.85, 1.12]; *P* = .720). Of note, 8 out of 12 independent variables were significant predictors on multivariable analysis. Age ≥65 years was associated with an OR of 3.40 for discharge to a facility of higher care (95% CI [2.92, 3.96]; *P* < .001). The ASA score (ASA 3–4: OR 2.06, 95% CI [1.77, 2.40]; *P* < .001) and CCI were associated with increased odds of failure to be discharged home (per-unit OR 1.26, 95% CI [1.09, 1.46]; *P* < .001). Multilevel surgery was associated with increased odds of failure to be discharged home (per-interspace OR 1.52, 95% CI [1.38, 1.67]; *P* < .001). Preoperative physical dependence (OR 2.03, 95% CI [1.41, 2.92]; *P* < .001) and hypertension (OR 1.26, 95% CI [1.08, 1.47]; *P* < .001) were associated with increased odds of failure to return home (Table 6). In contrast, male patients (OR 0.55, 95% CI [0.48, 0.63]; *P* < .001) and smokers (OR 0.73, 95% CI [0.61, 0.89]; *P* < .001) were less likely to fail to be discharged to home (Table 6). View this table: [Table 6](https://www.ijssurgery.com/content/12/5/533/T6) Table 6 Multivariable logistic regression for hospital discharge to home. Odds ratios (ORs) and associated 95% confidence intervals (CIs) are shown for each predictor. Patients who expired in hospital and/or within 30 days of operation were excluded from the analysis. No significant univariate difference was observed for mortality by surgery cohort, as 9 patients died in each the anterior and posterior cohorts (ALIF 0.22%, TLIF 0.22%; *P* = .842); hence, multivariable analysis was not performed. ### Early Complication and Reoperation Rates A greater proportion of patients undergoing TLIF suffered early complications (ALIF: 15.0%, TLIF: 16.9%; *P* = .016). This finding did survive multivariable analysis (TLIF: OR: 1.14, 95% CI [1.01, 1.29]; *P* = .034). As seen with discharge destination, older age, ASA score, functional dependency, hypertension, and number of vertebral levels all significantly increased patient likelihood of experiencing complications. Outpatient status (OR 0.47, 95% CI [0.28, 0.81]; *P* = .006) and male gender (OR 0.68, 95% CI [0.60, 0.77]; *P* < .001) were associated with lower odds of early complications (Table 7). View this table: [Table 7](https://www.ijssurgery.com/content/12/5/533/T7) Table 7 Multivariable logistic regression for early complication rates. Odds ratios (ORs) and associated 95% confidence intervals (CIs) are shown for each predictor. Patients who expired in hospital and/or within 30 days of operation were excluded from the analysis. To further characterize differences observed in early complication rates, individual complications were compared using multivariable analysis. On univariate analysis, the TLIF cohort was associated with a nonsignificant statistical trend in decreased rates of pneumonia (ALIF: 0.9% versus TLIF: 0.5%; *P* = .090) and need for prolonged ventilation (>24 hours) (ALIF: 0.4% versus TLIF: 0.1%, *P* = .062); these associations were both statistically significant on multivariable analysis (pneumonia: TLIF OR 0.55, 95% CI [0.32, 0.94]; *P* = .029; ventilatory assistance: TLIF OR 0.33, 95% CI [0.12, 0.84]; *P* = .021). The TLIF cohort had a greater incidence of UTIs (ALIF: 1.2% versus TLIF: 1.8%, *P* = .004) and blood transfusions >1 unit (ALIF: 10.9% versus TLIF: 11.5%, *P* = .014). Multivariable analysis demonstrated increased odds of UTI in the TLIF cohort (OR 1.57, 95% CI [1.10, 2.26]; *P* = .013), and a statistically significant trend persisted for patients requiring blood transfusions >1 unit (OR 1.19, 95% CI [1.04, 1.37]; *P* = .012; Table 8). View this table: [Table 8](https://www.ijssurgery.com/content/12/5/533/T8) Table 8 Univariate and multivariate comparison of major early complications. No significant differences in reoperation rates were observed between surgery cohorts (TLIF OR 1.04, 95% CI [0.80, 1.35]; *P* = .758). ## DISCUSSION The present analysis uses the NSQIP database for patients undergoing elective lumbar fusion surgeries from years 2011–2014. We show that, in general, TLIF patients have a higher preoperative health burden. While controlling for a number of demographic and clinical factors, we demonstrate that patients undergoing elective ALIF were less likely to suffer prolonged operative time, postoperative UTIs, or require blood transfusions. However, ALIF patients were at increased risk of pneumonia and prolonged ventilatory support. A primary consideration is how disc disease presents anatomically. In the healthy, young spine, 80% of the axial load is borne on the anterior portion of the vertebral body. Accordingly, ALIF provides surgeons with increased capacity to access and augment this load bearing portion of the spine with instrumentation.34 Visualization of the anterior spinal column allows for efficient discectomy and vertebral body distraction with minimal neurological insult. A major consideration in the anterior approach is the navigation through the peritoneal and retroperitoneal space. Not surprisingly, ALIF subjects were generally healthier and presented with fewer prior comorbidities, eg, cardiac surgery, diabetes, hypertension, obesity, and coagulopathy. The risk, however small, for serious bleeding complications with ALIF is another serious consideration. Benefits of a posterior approach include minimizing risk of serious vascular injury present when mobilizing the inferior vena cava and abdominal aorta to access the spine and potential cost saving due to eliminating the need to bill for an anterior access general surgeon. Even so, anterior approaches have been associated with reduced blood loss and decreased operative time,35,10,36 likely due to the lack of needing to dissect the paraspinous musculature required by posterior and posterolateral approaches. Increased operation time is known to associate with increased risk of infection, blood loss, and postoperative respiratory complications. Thus, operative time must be minimized in patients with significant health burden. As such, after clinical presentation and patient pathology are taken into account, decreased operative time associated with ALIF procedures may be another factor that can inform surgical decision making. Significant difference in demographic characteristics between our 2 cohorts suggests the TLIF cohort has more advanced pathology. Difficult anterior access due to morbid obesity or body habitus may be 1 factor that skews ALIF demographic characteristics towards healthier individuals. No difference was seen in discharge destination between ALIF and TLIF cohorts. Both surgeries also performed comparably on rates of most postoperative complications. Anterior lumbar interbody fusion subjects were more likely to require ventilatory assistance and/or develop pneumonia. This may be due to postoperative atelectasis related to the anterior approach. Urinary tract infections (1–2%) and the need for blood transfusions (10–11%) were the 2 most common complications following both surgeries and at higher likelihood following TLIF—important considerations for the dependent or coagulopathic patient. Notably, the number of vertebral levels fused was a significant predictor of all outcomes. This finding, while intuitive, highlights the importance of instrumentation and pathology in outcome prediction. Reported costs per procedure found that, across a 10-year sample of over 900 000 lumbar interbody fusions, ALIF procedures cost on average over $10 000 more.37 This increased cost can be accounted for in a highly specialized surgical team responsible for anterior approach surgeries and the cost of spinal implants. A previous meta-analysis has shown ALIF to be associated with increased HLOS when compared to TLIF.38 This was thought to be due to increased rates of postoperative complications such as ileus.39 Although our dataset did not specifically account for ileus, the lack of a significant difference between HLOS in ALIF and TLIF cohorts suggests similar rates of discharge preventing complications. This is reflected in the increasing trend of surgeons to choose posterior/posterolateral fusion techniques.37 In contrast, spine surgeons with fellowship training were 4 times as likely to choose ALIF over TLIF.19 The findings outlined in our paper are corroborated by a small study of 21 individuals in which ALIF surgeries significantly decreased operative time compared to TLIF .40 The current literature, however, has no clear consensus on outcomes when comparing anterior and posterior lumbar interbody fusion. Phan et al38 describe a meta-analysis using weighted means to compare ALIF and TLIF. They found ALIF was associated with longer hospitalizations, lower dural injuries, and higher blood vessel injuries.38 A recent meta-analysis comparing PLIF, ALIF, and TLIF between 30 studies found similar fusion rates and similar complication rates between the various methods for lumbar fusion.41 A retrospective study using the NSQIP database comparing single-level ALIF to single-level TLIF in a propensity matched cohort found no difference on any 30-day perioperative outcomes.42 In contrast to the results outlined in our study, Jiang et al43 found ALIF to be associated with increased operative time and blood loss than TLIF. In contrast, a meta-analysis of 651 patients found ALIF is associated with comparable or superior performance for operative time, blood loss, and fusion rates.36 The current paper offers a more detailed look at what specific complications are impacted by surgical approach while also having the largest sample size for determining differences in operative time, HLOS, and other perioperative outcomes. ### Limitations Retrospective database studies have inherent limitations. Discrepancies between data collection and entry are of primary concern. The NSQIP implementation of standardized data collector training and ongoing edits of data reliability have decreased errors to less than 1%.44,45 Also, CPT codes, International Classification of Diseases, Ninth Revision, diagnoses are still broad and often do not capture the full scope of clinical presentation. More specifically, the potential grouping of PLIF and TLIF procedures in our TLIF group offers another potential confounder to our data. Also, grouping of TLIF and minimally invasive TLIF procedures could impact outcome measures of HLOS and blood loss.46 Much specificity is lost by such broad groupings. Accordingly, conclusions between posterior and anterior approaches can be drawn, but specific conclusions between ALIF and TLIF should be tempered. The rates of posterior instrumentation in the ALIF group is another potential confounder. It stands to reason that this could make outcomes worse in the ALIF group because of increased operative time and chance for complications. Physician training, surgical cost, and regional differences may be important confounders requiring further study. Individual complications are disparate and may have different impacts on patient outcomes. A lack of data granularity, specifically the inability to account for different pathology and patient presentation, remains a shortcoming of retrospective studies. As described above, ALIF patients are more likely to present with stenosis as compared to TLIF patients who primarily present with degenerative disc disease. Due to the retrospective nature of this study, it is not possible to determine to what degree this difference in pathology impacted outcomes studied. While important, we hope that this is at least partially compensated through the large sample size afforded by the retrospective dataset. ## CONCLUSIONS In summary, both ALIF and TLIF were relatively safe, and both performed comparably on measures of mortality and most postsurgical complications. Patients undergoing elective single-level TLIF are generally older and present with increased comorbidities compared to single-level ALIF. Anterior lumbar interbody fusion is associated with decreased operative time, decreased incidence of UTI and blood transfusions, and increased incidence of respiratory complications. Hence, ALIF and TLIF may be of benefit to specific surgical subpopulations based on comorbidities and pathology. ## Acknowledgments The American College of Surgeons National Surgical Quality Improvement Program and the hospitals participating therein are the source of the data used herein; they have not verified and are not responsible for the statistical validity of the data analysis or the conclusions derived by the authors. ## Footnotes * **Disclosures and COI:** The authors report no conflicts of interests concerning the materials and methods of this study or findings outlined in this paper. This work was supported by the National Institutes of Health through a Medical Student Summer Research Training Opportunity for the summer of 2016. * ©International Society for the Advancement of Spine Surgery * Copyright © 2018 ISASS - This manuscript is generously published free of charge by ISASS, the International Society for the Advancement of Spine Surgery ## REFERENCES 1. 1 .Walker BF. The prevalence of low back pain: a systematic review of the literature from 1966 to 1998. *J Spinal Disord*. 2000;13(3):205–217. [CrossRef](https://www.ijssurgery.com/lookup/external-ref?access_num=10.1097/00002517-200006000-00003&link_type=DOI) [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=10872758&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) [Web of Science](https://www.ijssurgery.com/lookup/external-ref?access_num=000087579100003&link_type=ISI) 2. 2 .Katz JN. Lumbar disc disorders and low-back pain: socioeconomic factors and consequences. *J Bone Joint Surg Am*. 2006;88 (Suppl 2):21–24. [Abstract/FREE Full Text](https://www.ijssurgery.com/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NjoiamJqc2FtIjtzOjU6InJlc2lkIjtzOjEzOiI4OC9zdXBwbF8yLzIxIjtzOjQ6ImF0b20iO3M6MTk6Ii9panNzLzEyLzUvNTMzLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 3. 3 .Allen RT, Rihn JA, Glassman SD, Currier B, Albert TJ, Phillips FM. An evidence-based approach to spine surgery. *Am J Med Qual*. 2009;24(6 Suppl):15S–24S. [CrossRef](https://www.ijssurgery.com/lookup/external-ref?access_num=10.1177/1062860609348743&link_type=DOI) [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=19890181&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) 4. 4 .Cloward RB. The treatment of ruptured lumbar intervertebral discs by vertebral body fusion. I. Indications, operative technique, after care. *J Neurosurg*. 1953;10(2):154–168. [CrossRef](https://www.ijssurgery.com/lookup/external-ref?access_num=10.3171/jns.1953.10.2.0154&link_type=DOI) [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=13035484&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) [Web of Science](https://www.ijssurgery.com/lookup/external-ref?access_num=A1953YD69600007&link_type=ISI) 5. 5 .Southwick WO, Robinson RA. Surgical approaches to the vertebral bodies in the cervical and lumbar regions. *J Bone Joint Surg Am*. 1957;39-A(3):631–644. [Abstract/FREE Full Text](https://www.ijssurgery.com/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NjoiamJqc2FtIjtzOjU6InJlc2lkIjtzOjg6IjM5LzMvNjMxIjtzOjQ6ImF0b20iO3M6MTk6Ii9panNzLzEyLzUvNTMzLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 6. 6 .Harms J, Rolinger H. [A one-stager procedure in operative treatment of spondylolistheses: dorsal traction-reposition and anterior fusion (author's translation)]. *Z Orthop Ihre Grenzgeb*. 1982;120(3):343–347. [CrossRef](https://www.ijssurgery.com/lookup/external-ref?access_num=10.1055/s-2008-1051624&link_type=DOI) [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=7113376&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) [Web of Science](https://www.ijssurgery.com/lookup/external-ref?access_num=A1982NY19200021&link_type=ISI) 7. 7 .Zhang Q, Zhou M, Liu H, Xu Y, Ren Y. A comparison of posterior lumbar interbody fusion and transforaminal lumbar interbody fusion: a literature review and meta-analysis. *BMC Musculoskelet Disord*. 2014;15:367. 8. 8 .Hackenberg L, Halm H, Bullmann V, Vieth V, Schneider M, Liljenqvist U. Transforaminal lumbar interbody fusion: a safe technique with satisfactory three to five year results. *Eur Spine J*. 2005;14(6):551–558. [CrossRef](https://www.ijssurgery.com/lookup/external-ref?access_num=10.1007/s00586-004-0830-1&link_type=DOI) [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=15672243&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) [Web of Science](https://www.ijssurgery.com/lookup/external-ref?access_num=000231658000006&link_type=ISI) 9. 9 .Wang S-J, Han YC, Liu XM, et al. Fusion techniques for adult isthmic spondylolisthesis: a systematic review. *Arch Orthop Trauma Surg*. 2014;134(6):777–784. 10. 10 .Jiang S-D, Chen J-W, Jiang L-S. Which procedure is better for lumbar interbody fusion: anterior lumbar interbody fusion or transforaminal lumbar interbody fusion? *Arch Orthop Trauma Surg*. 2012;132(9):1259–1266. [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=22622795&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) 11. 11 .Phan K, Thayaparan GK, Mobbs RJ. Anterior lumbar interbody fusion versus transforaminal lumbar interbody fusion—systematic review and meta-analysis. *Br J Neurosurg*. 2015;29(5):705–711. 12. 12 .Dorward IG, et al. Transforaminal versus anterior lumbar interbody fusion in long deformity constructs: a matched cohort analysis. *Spine (Phila Pa 1976)*. 2013;38(12):E755–E762. 13. 13 .American College of Surgeons, National Surgical Quality Improvement Project. User Guide for the 2013 ACS NSQIP Participant Use Data File. 2014. Available at: [https://www.facs.org/∼/media/files/quality%20programs/nsqip/nsqip\_puf\_userguide\_2014.ashx](https://www.facs.org/~/media/files/quality%20programs/nsqip/nsqip_puf_userguide_2014.ashx). Accessed September 7, 2018. 14. 14 .Ingraham AM, Richards KE, Hall BL, Ko CY. Quality improvement in surgery: the American College of Surgeons National Surgical Quality Improvement Program approach. *Adv Surg*. 2010;44:251–267. [CrossRef](https://www.ijssurgery.com/lookup/external-ref?access_num=10.1016/j.yasu.2010.05.003&link_type=DOI) [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=20919525&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) 15. 15 .Hall BL, Hamilton BH, Richards K, Bilimoria KY, Cohen ME, Ko CY. Does surgical quality improve in the American College of Surgeons National Surgical Quality Improvement Program: an evaluation of all participating hospitals. *Ann Surg*. 2009;250(3):363–376. [CrossRef](https://www.ijssurgery.com/lookup/external-ref?access_num=10.1097/SLA.0b013e3181b4148f&link_type=DOI) [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=19644350&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) [Web of Science](https://www.ijssurgery.com/lookup/external-ref?access_num=000269361400002&link_type=ISI) 16. 16 .Hanauer DA, Englesbe MJ, Cowan JA Jr., Campbell DA. Informatics and the American College of Surgeons National Surgical Quality Improvement Program: automated processes could replace manual record review. *J Am Coll Surg*. 2009;208(1):37–41. [CrossRef](https://www.ijssurgery.com/lookup/external-ref?access_num=10.1016/j.jamcollsurg.2008.08.030&link_type=DOI) [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=19228500&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) [Web of Science](https://www.ijssurgery.com/lookup/external-ref?access_num=000262330500005&link_type=ISI) 17. 17 .Merkow RP, Ju MH, Chung JW, Hall BL, et al. Underlying reasons associated with hospital readmission following surgery in the United States. *JAMA*. 2015;313(5):483–495. [CrossRef](https://www.ijssurgery.com/lookup/external-ref?access_num=10.1001/jama.2014.18614&link_type=DOI) [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=25647204&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) 18. 18 .Pannell WC, Savin DD, Scott TP, Wang JC, Daubs MD. Trends in the surgical treatment of lumbar spine disease in the United States. *Spine J*. 2015;15(8):1719–1727. 19. 19 .Lubelski D, et al. Differences in the Surgical Treatment of Lower Back Pain Among Spine Surgeons in the United States. *Spine (Phila Pa 1976)*. 2016;41(11):978–986. 20. 20 .Barbagallo GMV, et al. Lumbar lateral interbody fusion (LLIF): comparative effectiveness and safety versus PLIF/TLIF and predictive factors affecting LLIF outcome. *Evid Based Spine Care J*. 2014;5(1):28–37. 21. 21 .Goldstein CL, Macwan K, Sundararajan K, Rampersaud YR. Perioperative outcomes and adverse events of minimally invasive versus open posterior lumbar fusion: meta-analysis and systematic review. *J Neurosurg Spine*. 2016;24(3):416–427. 22. 22 .Jones E, Oliphant T, Peterson P, et al. Open source scientific tools for Python. 2001. 23. 23 .Pedregosa F, Varoquaux G, Gramfort A, et al. Scikit-learn: Machine Learning in Python. *J Mach Learn Res*. 2011;12:2825–2830. 24. 24 .Seabold S, Perktold J. Statsmodels: econometric and statistical modeling with Python. *Proceedings of the 9th Python in Science Conference*. 2010. 25. 25 .Werner CA. The older population: 2010. *United States Census Bureau: 2010 Census Brief*. 2011. Available at: [http://www.census.gov/prod/cen2010/briefs/c2010br-09.pdf](http://www.census.gov/prod/cen2010/briefs/c2010br-09.pdf). 26. 26 .Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. *J Chronic Dis*. 1987;40(5):373–383. [CrossRef](https://www.ijssurgery.com/lookup/external-ref?access_num=10.1016/0021-9681(87)90171-8&link_type=DOI) [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=3558716&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) [Web of Science](https://www.ijssurgery.com/lookup/external-ref?access_num=A1987G855900002&link_type=ISI) 27. 27 .Kukreja S, Ambekar S, Ahmed OI, Menger RP, Sin AH, Nanda A. Impact of elective versus emergent admission on perioperative complications and resource utilization in lumbar fusion. *Clin Neurol Neurosurg*. 2015;136:52–60. 28. 28 .Walid MS, Robinson JS Jr.. Economic impact of comorbidities in spine surgery. *J Neurosurg Spine*. 2011;14(3):318–321. [CrossRef](https://www.ijssurgery.com/lookup/external-ref?access_num=10.3171/2010.11.SPINE10139&link_type=DOI) [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=21235301&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) 29. 29 .Winkler EA, et al. Perioperative morbidity and mortality after lumbar trauma in the elderly. *Neurosurg Focus*. 2015;39(4):E2. [CrossRef](https://www.ijssurgery.com/lookup/external-ref?access_num=10.3171/2015.9.FOCUS15497&link_type=DOI) 30. 30 .Boakye M, Maxwell B, Ryan M, Maiying K, Skirboll SL, Arrigo RT. Health-related quality-of-life status in veterans with spinal disorders. *Qual Life Res*. 2012;22(1):45–52. 31. 31 .Zanoli G. Outcome assessment in lumbar spine surgery. *Acta Orthop Suppl*. 2005;76(318):5–47. [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=16175972&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) 32. 32 .Fredman B, Arinzon Z, Zohar E, et al. Observations on the safety and efficacy of surgical decompression for lumbar spinal stenosis in geriatric patients. *Eur Spine J*. 2002;11(6):571–574. [CrossRef](https://www.ijssurgery.com/lookup/external-ref?access_num=10.1007/s00586-002-0409-7&link_type=DOI) [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=12522715&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) 33. 33 .Fu K-MG, Smith JS, Polly DW Jr, et al. Correlation of higher preoperative American Society of Anesthesiology grade and increased morbidity and mortality rates in patients undergoing spine surgery. *J Neurosurg Spine*. 2011;14(4):470–474. [CrossRef](https://www.ijssurgery.com/lookup/external-ref?access_num=10.3171/2010.12.SPINE10486&link_type=DOI) [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=21294615&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) 34. 34 .Mobbs RJ, Loganathan A, Yeung V, Rao PJ. Indications for anterior lumbar interbody fusion. *Orthop Surg*. 2013;5(3):153–163. 35. 35 .Burke PJ. Anterior lumbar interbody fusion. *Radiol Technol*. 2001;72(5):423–430. [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=11392300&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) 36. 36 .Udby PM, Bech-Azeddine R. Clinical outcome of stand-alone ALIF compared to posterior instrumentation for degenerative disc disease: a pilot study and a literature review. *Clin Neurol Neurosurg*. 2015;133:64–69. 37. 37 .Goz V, Weinreb JH, Schwab F, Lafage V, Errico TJ. Comparison of complications, costs, and length of stay of three different lumbar interbody fusion techniques: an analysis of the Nationwide Inpatient Sample database. *Spine J*. 2014;14(9):2019–2027. 38. 38 .Phan K, Thayaparan GK, Mobbs RJ. Anterior lumbar interbody fusion versus transforaminal lumbar interbody fusion–systematic review and meta-analysis. *Br J Neurosurg*. 2015;29(5):705–711. 39. 39 .Qureshi R, et al. A comparison of anterior and posterior lumbar interbody fusions—complications, readmissions, discharge dispositions and costs. *Spine (Phila Pa 1976)*. 2017;42(24):1865–1870. 40. 40 .Udby PM, Bech-Azeddine R. Clinical outcome of stand-alone ALIF compared to posterior instrumentation for degenerative disc disease: a pilot study and a literature review. *Clin Neurol Neurosurg*. 2015;133:64–69. 41. 41 .Teng I, Han J, Phan K, Mobbs K. A meta-analysis comparing ALIF, PLIF, TLIF and LLIF. *J Clin Neurosci*. 2017;44:11–17. 42. 42 .Gala RJ, Bovonratwet P, Webb ML, Varthi AG, Daubs MD, Grauer JN. Different fusion approaches for single-level lumbar spondylolysis have similar perioperative outcomes. *Spine (Phila Pa 1976)*. 2018;43(2):E111–E117. 43. 43 .Jiang SD, Chen JW, Jiang LS. Which procedure is better for lumbar interbody fusion: anterior lumbar interbody fusion or transforaminal lumbar interbody fusion? *Arch Orthop Trauma Surg*. 2012;132(9):1259–1266. [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=22622795&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) 44. 44 .Huffman KM, Cohen ME, Ko CY, Hall BL. A comprehensive evaluation of statistical reliability in ACS NSQIP profiling models. *Ann Surg*. 2015;261(6):1108–1113. 45. 45 .Shiloach M, Frencher SK Jr, Steeger JE, et al. Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. *J Am Coll Surg*. 2010;210(1):6–16. [CrossRef](https://www.ijssurgery.com/lookup/external-ref?access_num=10.1016/j.jamcollsurg.2009.09.031&link_type=DOI) [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=20123325&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom) 46. 46 .Author. Minimally invasive versus open transforaminal lumbar interbody fusion for degenerative spondylolisthesis: comparative effectiveness and cost-utility analysis. *World Neurosurg*. 2014;82(1–2):230–238. [PubMed](https://www.ijssurgery.com/lookup/external-ref?access_num=23321379&link_type=MED&atom=%2Fijss%2F12%2F5%2F533.atom)